Neuromedin U (NMU) is a neuropeptide expressed in several peripheral tissues that could be considered a potential bridge between metabolic disorders and inflammation and a good candidate as a biomarker in CVD risk assessment [6,7]. Here, NMU is linked to metabolic disease.